These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22446473)

  • 41. The Gateway Paper--context and configuration of the proposed health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S2-13. PubMed ID: 17595829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-Sector Collaborations And Partnerships: Essential Ingredients To Help Shape Health And Well-Being.
    Towe VL; Leviton L; Chandra A; Sloan JC; Tait M; Orleans T
    Health Aff (Millwood); 2016 Nov; 35(11):1964-1969. PubMed ID: 27834234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four disruptive strategies for removing drug discovery bottlenecks.
    Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
    Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoting collaborations that improve health.
    Lasker RD; Weiss ES; Miller R;
    Educ Health (Abingdon); 2001; 14(2):163-72. PubMed ID: 14742015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of institutions and organizations on urban waste collection systems: an analysis of waste collection system in Accra, Ghana (1985-2000).
    Fobil JN; Armah NA; Hogarh JN; Carboo D
    J Environ Manage; 2008 Jan; 86(1):262-71. PubMed ID: 17291677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Healthy partnerships, healthy citizens? An international review of partnerships in health and social care and patient/user outcomes.
    Rummery K
    Soc Sci Med; 2009 Dec; 69(12):1797-804. PubMed ID: 19828221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Collaboration Challenge: Global Partnerships to Achieve Global Goals.
    Bzdak M
    World Health Popul; 2017; 17(3):81-92. PubMed ID: 29400276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Align, share responsibility and collaborate: potential considerations to aid in e-health policy development.
    Ragaban N; Day K; Orr M
    Stud Health Technol Inform; 2012; 178():186-91. PubMed ID: 22797040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Collaboration across private and public sector primary health care services: benefits, costs and policy implications.
    McDonald J; Powell Davies G; Jayasuriya R; Fort Harris M
    J Interprof Care; 2011 Jul; 25(4):258-64. PubMed ID: 21554068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving public health system performance through multiorganizational partnerships.
    Mays GP; Scutchfield FD
    Prev Chronic Dis; 2010 Nov; 7(6):A116. PubMed ID: 20950523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding change in global health policy: ideas, discourse and networks.
    Harmer A
    Glob Public Health; 2011; 6(7):703-18. PubMed ID: 20924870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine".
    Desiere F; Romano Spica V
    N Biotechnol; 2012 Sep; 29(6):611-2. PubMed ID: 22504736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progress in public-private partnerships to fight neglected diseases.
    Gustavsen K; Hanson C
    Health Aff (Millwood); 2009; 28(6):1745-9. PubMed ID: 19887415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Precarious connections: making therapeutic production happen for malaria and tuberculosis.
    Craddock S
    Soc Sci Med; 2015 Mar; 129():36-43. PubMed ID: 25142906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Institutional obstacles to expansion of world food production.
    Crosson PR
    Science; 1975 May; 188(4188):519-24. PubMed ID: 17740002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No-fee university licenses spur biotech partnerships.
    Moran N
    Nat Biotechnol; 2013 May; 31(5):376. PubMed ID: 23657381
    [No Abstract]   [Full Text] [Related]  

  • 57. Analysing stratified medicine business models and value systems: innovation-regulation interactions.
    Mittra J; Tait J
    N Biotechnol; 2012 Sep; 29(6):709-19. PubMed ID: 22440585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New collaboration aims to aid target validation and drive drug discovery.
    Wilson H
    Pharmacogenomics; 2014 Apr; 15(6):732. PubMed ID: 25022024
    [No Abstract]   [Full Text] [Related]  

  • 59. Opportunities in biotechnology.
    Gartland KMA; Gartland JS
    J Biotechnol; 2018 Sep; 282():38-45. PubMed ID: 29890193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Public-private relationships in biobanking: a still underestimated key component of open innovation.
    Hofman P; Bréchot C; Zatloukal K; Dagher G; Clément B
    Virchows Arch; 2014 Jan; 464(1):3-9. PubMed ID: 24337181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.